Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The veteran's claim for a higher rating for tinea pedis was denied because the condition does not affect at least five percent of the body area and does not require systemic therapy.

Service connection for a skin condition, including tinea versicolor, is granted. The claim for service connection for left foot plantar fasciitis as secondary to a service-connected disability is remanded.

The Veteran's appeal for a total disability rating based on individual unemployability (TDIU) has been granted. The Board found that the Veteran's service-connected disabilities preclude him from obtaining or maintaining gainful employment.

The Board granted initial ratings of 30 percent, 40 percent, and 20 percent for dermatitis and tinea versicolor, lumbar spine disorder, and left lower extremity radiculopathy (sciatic nerve) respectively. The issues of service connection for rhinitis and sinusitis were remanded.

The Board remands the matter for further development, including a new VA examination to assess the current severity of the Veteran's service-connected skin condition.

The Board remanded the claims for an initial compensable rating for psoriasis with rosacea and tinea cruris, and for a rating in excess of 30 percent for IBS with GERD. New VA examinations are required to assess the severity of these conditions.

The Board remanded the veteran's claims for service connection of pseudofolliculitis barbae and tinea pedis to obtain a direct service connection nexus opinion.

The veteran's eczema rating was increased to 60%, but the claim for ethmoid sinusitis was denied.

The Board granted the veteran a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities.

The veteran's disability ratings for low back and left sciatic nerve issues were restored to previous levels. Claims for erectile dysfunction and pseudofolliculitis were denied. Other issues, including service connection for headaches and hypertension, were remanded.

The veteran's claims for service connection for unspecified dermatitis and right shoulder disability were granted. The claim for an initial compensable rating for allergic rhinitis was denied, and the claim for service connection for chronic fatigue syndrome was remanded.

The veteran is granted an effective date of July 8, 2020 for a 10% rating but denied a higher rating.

The veteran's appeal for service connection of bilateral neuropathy, chloracne/cutane tarda, and coronary artery disease was dismissed because the veteran requested to withdraw the appeal.

The veteran's claims for service connection for several conditions were denied. However, the veteran was granted an initial 10 percent rating for Bell's palsy and an initial 50 percent rating for migraine headaches and sleep apnea. Several other issues were remanded for further review.

The Board denied the veteran's claims for an earlier effective date and higher ratings for eczema and bilateral eye disability, as well as dismissed the claim for shortness of breath.

The Board denied a rating higher than 30% for eczema with lichenification. The Veteran's condition requires systemic therapy but not constantly.

The Board granted some issues, denied others, and remanded several for further development. The veteran's ratings for onychomycosis and GERD were restored to 30 percent. Effective dates for service connection for right shoulder surgical scars and lumbar spine surgical scar were granted. Several other issues were denied or dismissed.

The Board remanded the claim for service connection for skin disability, including actinic keratoses and seborrheic dermatitis, due to errors in assisting the veteran with obtaining necessary records.

The veteran's disability rating for bilateral hearing loss was reduced to noncompensable, and claims for other conditions were denied. Some issues were remanded for further review.

The Board remands the claims for further development, including obtaining a VA examination during a flare-up and attempting to secure private treatment records.